Atea Pharmaceuticals Inc (AVIR) — Cash Flow Reinvestment Rate
Atea Pharmaceuticals Inc (AVIR) has a Cash Flow Reinvestment Rate of 0.00x as of September 2021, reinvesting $4.00K (capex $4.00K ) from operating cash flow of $22.60 Million. See free cash flow generation of Atea Pharmaceuticals Inc to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Atea Pharmaceuticals Inc Cash Flow Reinvestment Rate (2020–2020)
Historical reinvestment intensity for Atea Pharmaceuticals Inc across 1 annual periods. For the full cash flow conversion analysis, see Atea Pharmaceuticals Inc (AVIR) cash conversion ratio.
Annual Cash Flow Reinvestment Rate for Atea Pharmaceuticals Inc (2020–2020)
Year-by-year capital reinvestment analysis for Atea Pharmaceuticals Inc. See financial agility of Atea Pharmaceuticals Inc to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2020 | 0.00x | $52.00K | $296.73 Million | $26.00K | — |